Teva reaches $4.25B settlement in national opioid cases

Teva Pharmaceuticals, an Israel-based drug manufacturer, has agreed to settle more than 3,000 opioid cases up to $4.25 billion in all cash over the next 13 years, according to The New York Times and Bloomberg. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive